findmyKOL

Soshian Sarrafpour, MD

Basic profile

Yale University

ORCIDNone on fileNPI
RegionNew Haven, CT · NortheastSpecialtyOphthalmologyFocusOphthalmology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Soshian Sarrafpour is an Ophthalmology physician affiliated with Yale University. OpenAlex indexes 33 publications with 234 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
33publications

Distinct works indexed by OpenAlex.

234citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85.1%
    Prostaglandin Analog35.5%
    Latanoprost83%Lumigan10%Travoprost7%
    Part D155 patients
    alpha-Adrenergic Agonist17.9%
    Brimonidine Tartrate50%Combigan23%Brimonidine Tartrate-Timolol16%Alphagan P11%
    Part D<11 patients

    + 8 more classes in this area

  • Cardiovascular

    6.6%
    Beta blocker6.6%
    Timolol Maleate100%
    Part D51 patients
  • Anti-infectives

    3.8%
    Macrolide2.1%
    Erythromycin100%
    Part D12 patients
    Fluoroquinolone Antibacterial0.9%
    Moxifloxacin100%
    Part D13 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”